Cargando…

Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms

The kynurenine pathway (KP) and the endocannabinoid system (ECS) are known to be deregulated in depression and obesity; however, it has been recognized that acute physical exercise has an important modulating role inducing changes in the mobilization of their respective metabolites—endocannabinoids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wences Chirino, Tiffany, Rangel López, Edgar, Luna Angulo, Alexandra, Carrillo Mora, Paul, Landa Solis, Carlos, Samudio Cruz, María Alejandra, Fuentes Bello, Alim C., Paniagua Pérez, Rogelio, Ríos Martínez, Juan, Sánchez Chapul, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609722/ https://www.ncbi.nlm.nih.gov/pubmed/37895892 http://dx.doi.org/10.3390/ph16101421

Ejemplares similares

Characterization of Redox Environment and Tryptophan Catabolism through Kynurenine Pathway in Military Divers’ and Swimmers’ Serum Samples
por: Sánchez Chapul, Laura, et al.
Publicado: (2022)

Targeting the Endocannabinoidome in Pancreatic Cancer
por: Falasca, Valerio, et al.
Publicado: (2022)

Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
por: Di Marzo, Vincenzo, et al.
Publicado: (2019)

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
por: Ishiguro, Hiroki
Publicado: (2023)

Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome
por: Forteza, Fabiola, et al.
Publicado: (2021)

Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity
por: Staats Pires, Ananda, et al.
Publicado: (2020)

Dietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
por: Castonguay-Paradis, Sophie, et al.
Publicado: (2023)

Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice
por: Lacroix, Sébastien, et al.
Publicado: (2019)

Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity
por: Manca, Claudia, et al.
Publicado: (2021)

The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders 
por: Di Marzo, Vincenzo
Publicado: (2020)

The Gut Microbiome–Endocannabinoidome Axis: A New Way of Controlling Metabolism, Inflammation, and Behavior
por: Silvestri, Cristoforo, et al.
Publicado: (2023)

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint †
por: Schiano Moriello, Aniello, et al.
Publicado: (2022)

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
por: Piscitelli, Fabiana, et al.
Publicado: (2011)

Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat
por: Castonguay-Paradis, Sophie, et al.
Publicado: (2020)

Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproductive-Aged Women Living with Overweight and Obesity
por: Manca, Claudia, et al.
Publicado: (2021)

Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study
por: Forteza, Fabiola, et al.
Publicado: (2022)

Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice
por: Venneri, Tommaso, et al.
Publicado: (2023)

Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome
por: Shen, Mélissa, et al.
Publicado: (2021)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis
por: Abolghasemi, Armita, et al.
Publicado: (2021)

The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
por: Lauritano, Anna, et al.
Publicado: (2022)

Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review
por: Kiluk, Małgorzata, et al.
Publicado: (2021)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

On the Antioxidant Properties of L-Kynurenine: An Efficient ROS Scavenger and Enhancer of Rat Brain Antioxidant Defense
por: Ramírez Ortega, Daniela, et al.
Publicado: (2021)

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models
por: Depommier, Clara, et al.
Publicado: (2021)

332 Role of Kynurenine/Tryptophan Ratio in Kidney-Lung crosstalk in two porcine trauma-induced multi-organ injury models
por: Singh, Pragya, et al.
Publicado: (2023)

Cluster headache and kynurenines
por: Tuka, Bernadett, et al.
Publicado: (2023)

Characteristic Features of Kynurenine Aminotransferase Allosterically Regulated by (Alpha)-Ketoglutarate in Cooperation with Kynurenine
por: Okada, Ken, et al.
Publicado: (2012)

Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
por: Depommier, Clara, et al.
Publicado: (2021)

Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
por: Carrillo-Mora, Paul, et al.
Publicado: (2014)

Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case–control study
por: Natsuko, Paniagua-Díaz, et al.
Publicado: (2022)

Imbalanced Kynurenine Pathway in Schizophrenia
por: Kegel, Magdalena E, et al.
Publicado: (2014)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Kynurenine pathway metabolites in migraine
por: Nicoletti, Ferdinando
Publicado: (2015)

Kynurenine: an oncometabolite in colon cancer
por: Venkateswaran, Niranjan, et al.
Publicado: (2020)

Kynurenine pathway in kidney diseases
por: Zakrocka, Izabela, et al.
Publicado: (2021)

Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine
por: Forrest, C.M., et al.
Publicado: (2015)

Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
por: Reyes Ocampo, Jazmin, et al.
Publicado: (2014)

FACTORS AFFECTING THE INTRACELLUALR SYNTHESIS OF KYNURENINE
por: Rizki, T. M., et al.
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_893cdb9qme61gr35m475jq0vr8